
Venture capital · Growth stage
Pandect
Pandect Catalyst Fund, working with the Berkeley Catalyst Fund, is a venture investor backing deep tech companies that emerge from university and research ecosystems, with emphasis on healthcare and sustainability.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Pandect right for your round?
Key stats
Fund cycle Public record
No fund vehicles on the public registers we read.
Latest investments
Rounds Pandect joined, from press and the firm’s own posts.
Every round Pandect joined
Round sizes, Pandect’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Pandect backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Pandect
Events where Pandect’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Pandect is based in Woodside, United States.
Stages: Late stage. Sectors: Biotech, Medtech, Food and agtech, Deep tech and hardware, AI, Software, Climate and energy. From the firm’s own website.
Invests in transformative, broadly applicable deep tech platforms, drawing on the UC Berkeley and UCSF ecosystem for deal flow and company building. It aims to advance disease prevention and therapy, renewable energy and sustainable agriculture, with a people, planet, profit mindset. From the firm’s own website.
Up to $3M per investment, according to the firm’s own website.
Pandect lists 2 portfolio companies on its website: Circle Pharma and 4DMT.
Firms whose websites list some of the same companies include AWESOME ENABLERS, L.L.C., Mission BioCapital and RA Capital.
Know before Pandect’s next round is announced.
PRO tracks Pandect’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.